The invention discloses compounds of Formula (I)
wherein R
1
, R
2
, R
2A
, R
3
, R
3A
, R
4
, and R
5
are as defined herein. The present invention relates to compounds and their use in the treatment of cystic fibrosis, methods for their production, pharmaceutical compositions comprising the same, and methods of treating cystic fibrosis by administering a compound of the invention.
Facile Synthesis of 2-Acylthieno[2,3-<i>b</i>]quinolines via Cu-TEMPO-Catalyzed Dehydrogenation, sp<sup>2</sup>-C–H Functionalization (Nucleophilic Thiolation by S<sub>8</sub>) of 2-Haloquinolinyl Ketones
作者:Chitrala Teja、Fazlur Rahman Nawaz Khan
DOI:10.1021/acs.orglett.9b04598
日期:2020.3.6
An efficient, solvent-free synthesis of 2-acylthieno[2,3-b]quinolines is reported from 2-halo-quinolinyl ketones through Cu-TEMPO catalyzed dehydrogenation, sp2-C-H functionalization using elemental sulfur as thiol surrogate (sulfur source) and tetrabutylammonium acetate as an ionic reaction medium. The optimized reaction conditions give excellent product yields under mild reaction conditions with
Ir(I)‐Catalyzed Synthesis of (
<i>E</i>
)‐4‐Benzylidenylacridines and (
<i>E</i>
)‐2‐Styrylquinoline‐3‐carboxamide through Sequential Suzuki–Miyaura Coupling, Dehydrogenative Friedländer Reaction, and sp
<sup>3</sup>
‐C–H Activation
作者:Soda Prameela、Fazlur‐Rahman Nawaz Khan
DOI:10.1002/ejoc.202000834
日期:2020.9.7
DESs mediated three (or) four‐component one‐pot assembly of (E)‐4‐benzylidenylacridin‐1(2H)‐ones (E)‐2‐styryl quinoline‐3‐carboxamides is described. The method involves the consecutive three carbon–carbon and one carbon–nitrogen bond formation in a single reaction vessel. Moreover, gram scale synthesis and detailed mechanistic study have been established.
Triazolothiadizepinylquinolines as potential MetAP-2 and NMT inhibitors: Microwave-assisted synthesis, pharmacological evaluation and molecular docking studies
作者:Saba Kauser J. Shaikh、Ravindra R. Kamble、Praveen K. Bayannavar、Shilpa M. Somagond、Shrinivas D. Joshi
DOI:10.1016/j.molstruc.2019.127445
日期:2020.3
The enzymes MetAP-2 and NMT play a crucial role in the process of myristoylation of oncoproteins which is deregulated in many types of cancers. Execution of both these enzymes is considered as strategy for the intervention of various cancers and relative fungal infections, and hence the discovery of novel MetAP-2 and NMT inhibitors necessitate their high relevancy. In this investigation, we have synthesized a series of novel seven-membered triazolothiadiazepinyl quinolines 10(a-m) distinctively under microwave irradiation technique and identified as selective MetAP-2 and NMT inhibitors. Amongst the functionalized derivatives when evaluated for the in vitro antifungal assay, compounds 10b, 10c, 10e and 10f were considered promising due to notable inhibitory effects (MIC = 0.2 mg/mL) on Aspergillus fumigatus. Screening of the anticancer activity against NCI-60 Human tumor cell lines portrayed that conjugates 10b, 10c, 10e and 10f were found to be moderately effective against the Renal Cancer cell line UO-31. The data acquired from biological studies was further validated by molecular docking studies and p harmaco kinetic evaluation. (C) 2019 Elsevier B.V. All rights reserved.